{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2006"],"condition":["Colorectal Carcinoma","Carcinoma","Colorectal Neoplasms"],"disease":["Colorectal Carcinoma","Carcinoma","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2034888"],"location":["Germany"],"study_start_month":["10"],"keyword":["Advanced Colorectal Carcinoma"],"repository":["ECRIN MDR"],"study_status":["Terminated"],"additional_accession":[]},"is_claimable":false,"name":"Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003","description":"The purpose of the study is to evaluate efficacy and safety of AMT2003 in cancer patients with advanced colorectal carcinoma.\nThe primary endpoint is progression free survival rate at 18 weeks after registration","dates":{"creation":"2006-10-15"},"accession":"2034888","cross_references":{"ClinicalTrials___gov":["NCT00405561"]}}